PolyPid Ltd. (Nasdaq: PYPD ), a late-stage biopharma company aiming to improve surgical outcomes through locally administered, controlled, extended-release therapeutics, today announced that members of its executive management team will present at three upcoming healthcare investor conferences. Key presentation details include: The 2021 LD Micro Invitational XI Date : Thursday, June 10, 2021 Time : 10:30 a.m. ET
June 2, 2021
· 3 min read